SEC Form 4 Reporting Owner · CIK 0001563572
William J Chase
Director at Grail Inc · Director at Intellia Therapeutics Inc
Bought (12 mo)
—
Sold (12 mo)
—
Form 4 Filings
19
Companies
2
Filing Activity
2026-10-16
first filed 2023-04-18
Trading record
Open-market buys
+$1M
1 filing
Open-market sales
—
0 filings
Sales under a 10b5-1 plan
—
No open-market sales
Companies
| Company | Role | Filings | Bought | Sold | Net | Holding after latest filing |
|---|---|---|---|---|---|---|
| GRALGRAIL Insider trading | Director | 13 | — | — | — | 43,131 2026-10-16 |
| NTLAIntellia Therapeutics Insider trading | Director | 6 | 100,000 | — | +100,000 | 143,893 2026-06-10 |
Common-stock shares bought and sold on the open market, as reported on Form 4. The holding is what the latest filing at each company reported owning after its transactions.